The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Open accessAbstract
Adverse drug reactions (ADRs) are a major cause of hospital admissions, but recent data on the incidence and clinical characteristics of ADRs which occur following hospital admission, are lacking. Patients admitted to twelve wards over a six-month period in 2005 were assessed for ADRs throughout their admission. Suspected ADRs were recorded and analysed for causality, severity and avoidability and whether they increased the length of stay. Multivariable analysis was undertaken to identify the risk factors for ADRs. The 5% significance level was used when assessing factors for inclusion in multivariable models. Out of the 3695 patient episodes assessed for ADRs, 545 (14.7%, 95% CI 13.6-15.9%) experienced one or more ADRs. Half of ADRs were definitely or possibly avoidable. The patients experiencing ADRs were more likely to be older, female, taking a larger number of medicines, and had a longer length of stay than those without ADRs. However, the only significant predictor of ADRs, from the multivariable analysis of a representative sample of patients, was the number of medicines taken by the patient with each additional medication multiplying the hazard of an ADR episode by 1.14 (95% CI 1.09, 1.20). ADRs directly increased length of stay in 147 (26.8%) patients. The drugs most frequently associated with ADRs were diuretics, opioid analgesics, and anticoagulants. In conclusion, approximately one in seven hospital in-patients experience an ADR, which is a significant cause of morbidity, increasing the length of stay of patients by an average of 0.25 days/patient admission episode. The overall burden of ADRs on hospitals is high, and effective intervention strategies are urgently needed to reduce this burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914 · cited 2×
“2%) suspected ADRs were subsequently excluded by the investigating team, on the basis that an ADR was unlikely to be drug related according to the Naranjo algorithm [15].”
MethodIncidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
Self-citationAdverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention
Bates, D. W. (1995) · JAMA · doi:10.1001/jama.1995.03530010043033 · Cited by 2,127
Bates, D. W. (1997) · JAMA · doi:10.1001/jama.277.4.307 · Cited by 1,674
Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit
Leape, L. L. (1999) · JAMA · doi:10.1001/jama.282.3.267 · Cited by 1,599
Applied Mixed Models in Medicine
Brown, H., & Presco, R. (2000) · Technometrics · doi:10.1080/00401706.2000.10485742 · Cited by 1,262
Classen, D. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280039031 · Cited by 1,134
The Costs of Adverse Drug Events in Hospitalized Patients
Bates, D. W. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280045032 · Cited by 1,068
Preventability and severity assessment in reporting adverse drug reactions
Hartwig, S. C., Siegel, J., & Schneider, P. J. (1992) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/49.9.2229 · Cited by 920
Causes of prescribing errors in hospital inpatients: a prospective study
Dean, B., Schachter, M., Vincent, C., & Barber, N. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08350-2 · Cited by 674
Incidence of adverse drug events and potential adverse drug events
Bates, D. W., Cullen, D. J., & Laird, N. (1995) · International Journal of Trauma Nursing · doi:10.1016/s1075-4210(05)80011-2 · Cited by 534
Kucukarslan, S. N., Peters, M., Mlynarek, M., & Nafziger, D. A. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.17.2014 · Cited by 514
Applied Mixed Models in Medicine
Ziegel, E. R., Brown, H., & Prescott, R. (2000) · Technometrics · doi:10.2307/1270978 · Cited by 447
HALLAS, J., HARVALD, B., GRAM, L. F., GRODUM, E., BRØSEN, K., HAGHFELT, T., & DAMSBO, N. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00199.x · Cited by 377
PHARMACEUTICAL SOCIETY OF GREAT BRITAIN.
Hill, A. (1930) · The Lancet · doi:10.1016/s0140-6736(00)86391-6 · Cited by 376
Methods for Causality Assessment of Adverse Drug Reactions: A Systematic Review
Agbabiaka, T. B., Savović, J., & Ernst, E. (2008) · Drug Safety · doi:10.2165/00002018-200831010-00003 · Cited by 366
Raschke, R. A., Gollihare, B., Wunderlich, T. A., Guidry, J. R., Leibowitz, A. I., Peirce, J. C., Lemelson, L., Heisler, M. A., & Susong, C. (1998) · JAMA · doi:10.1001/jama.280.15.1317 · Cited by 357
Incidence of fatal adverse drug reactions: a population based study
Wester, K., Jönsson, A. K., Spigset, O., Druid, H., & Hägg, S. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03064.x · Cited by 340
Textbook of Adverse Drug Reactions.
(1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-5-667_1 · Cited by 337
Frequency and cost of serious adverse drug reactions in a department of general medicine
Moore, N., Lecointre, D., Noblet, C., & Mabille, M. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00667.x · Cited by 322
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Studies on the Epidemiology of Adverse Drug Reactions: An Evaluation of Penicillin Allergy
Smith, J. W., Johnson, J. E., & Cluff, L. E. (1966) · New England Journal of Medicine · doi:10.1056/nejm196605052741804 · Cited by 316
SMITH, J. W., SEIDL, L. G., & CLUFF, L. E. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-65-4-629 · Cited by 305
Joining the DoTS: new approach to classifying adverse drug reactions
Aronson, J. K., & Ferner, R. E. (2003) · BMJ · doi:10.1136/bmj.327.7425.1222 · Cited by 297
Intensive Hospital Monitoring of Adverse Reactions to Drugs
Hurwitz, N., & Wade, O. L. (1969) · BMJ · doi:10.1136/bmj.1.5643.531 · Cited by 294
Is Age an Independent Risk Factor of Adverse Drug Reactions in Hospitalized Medical Patients?*
Carbonin, P., Bernabei, R., & Sgadari, A. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb02875.x · Cited by 292
Clinical and Economic Impact of Adverse Drug Reactions in Hospitalized Patients
Suh, D.-C., Woodall, B. S., Shin, S.-K., & Hermes-De Santis, E. R. (2000) · The Annals of Pharmacotherapy · doi:10.1345/1542-6270(2000)034<1373:caeioa>2.0.co;2 · Cited by 230
Howard, R. L. (2003) · Quality and Safety in Health Care · doi:10.1136/qhc.12.4.280 · Cited by 228
Pathogenesis of adverse drug reactions
Rawlins, M. D. (1977) · Medical Entomology and Zoology · Cited by 196
Preventing Adverse Drug Events in Hospitalized Patients
Evans, R. S., Pestotnik, S. L., Classen, D. C., Horn, S. D., Bass, S. B., & Burke, J. P. (1994) · Annals of Pharmacotherapy · doi:10.1177/106002809402800417 · Cited by 161
Adverse drug reactions during hospitalization.
OGILVIE, R. I., & Ruedy, J. (1967) · PubMed · Cited by 157
Adverse Drug Reactions in Hospitals: A Narrative Review
Davies, E. C., Green, C. F., Mottram, D. R., & Pirmohamed, M. (2007) · Current Drug Safety · doi:10.2174/157488607779315507 · Cited by 112
Self-citationRisk factors for the development of adverse drug events in hospitalized patients.
van den Bemt, P. M. L. A., Egberts, T. C. G., Lenderink, A. W., Verzijl, J. M., Simons, K. A., van der Pol, W. S. C. J. M., & Leufkens, H. G. M. (2000) · Pharmacy World & Science · doi:10.1023/a:1008721321016 · Cited by 102
Adverse drug reactions: a cohort study in internal medicine units at a university hospital
Camargo, A. L., Ferreira, M. B. C., & Heineck, I. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0086-7 · Cited by 94
Epidemiological Studies of Adverse Drug Reactions
Seidl, L. G., Thornton, G. F., & Cluff, L. E. (1965) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.55.8.1170 · Cited by 88
Adverse drug reactions in hospital in-patients: a pilot study
Davies, E. C., Green, C. F., Mottram, D. R., et al. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00744.x · Cited by 87
Self-citationAdverse drug reactions in hospitalized patients: A critique of a meta-analysis.
Kvasz, M., Allen, I., Mj, G., Ey, R., Estok, R. P., Olkin, I., & Ross, S. D. (2000) · PubMed · Cited by 55
Analysis of adverse drug reactions for preventability
Ducharme, M. M., & Boothby, L. A. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01130.x · Cited by 47
Risk factors for adverse drug reactions ? epidemiological approaches
Hoign�, R., Lawson, D. H., & Weber, E. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315403 · Cited by 40
Pirmohamed, M., & Ferner, R. E. (2003) · BMJ · doi:10.1136/bmj.327.7425.1179 · Cited by 38
Self-citation
Cited by
Hah, J. M., Bateman, B. T., Ratliff, J., Curtin, C., & Sun, E. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002458 · Cited by 728
Adverse drug reactions in special populations – the elderly
Davies, E. A., & O'Mahony, M. S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12596 · Cited by 604
Self-citationClinical and economic burden of adverse drug reactions
Sultana, J., Cutroneo, P., & Trifirò, G. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.120957 · Cited by 528
Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies
Bouvy, J. C., De Bruin, M. L., & Koopmanschap, M. A. (2015) · Drug Safety · doi:10.1007/s40264-015-0281-0 · Cited by 466
Economic analysis of the prevalence and clinical and economic burden of medication error in England
Elliott, R. A., Camacho, E., Jankovic, D., Sculpher, M. J., & Faria, R. (2021) · BMJ Quality & Safety · doi:10.1136/bmjqs-2019-010206 · Cited by 425
Metadata
- Authors
- Davies, E. C., Green, C. F., Taylor, S., Williamson, P. R., Mottram, D. R., & Pirmohamed, M.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-02-11
- Volume
- 4
- Issue
- 2
- Pages
- e4439
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2085074082
- Cited by
- 692
- References
- 43
- FWCI
- 51.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.